Stem cell therapy for recent spinal cord injury
Part of Brain & nervous system, Injuries & trauma clinical trials.
This phase 1 trial tests a new treatment made from stem cells (XS228) for people who had a spinal cord injury 14 to 60 days ago. Doctors want to see if it's safe and if it might help with recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You had a spinal cord injury in your neck or back (from C4 to L2) 2 weeks to 2 months ago.
- Your injury is rated as AIS grade A, B, or C (complete or incomplete, but not the mildest).
- You are healthy enough for a spinal tap (lumbar puncture) and can take medicines that suppress your immune system.
- You are not pregnant and are using effective birth control (non-hormonal) during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new cell therapy (XS228) can help people with recent spinal cord injuries recover function. The cells are given through a spinal tap and are designed to replace damaged nerve cells.
This trial tests a combination of stem cells injected into the spinal fluid and a non-invasive spinal cord stimulation device to see if they can improve recovery after a spinal cord injury. It is for people who have had a single traumatic injury between neck and mid-back, 1 to 5 years ago, and are in stable health.
This study tests a new treatment for spinal cord injury that is given through a spinal tap. It is for people with a recent or past spinal cord injury who are at least 18 years old. The treatment may help improve recovery.
This trial tests whether transplanting cells from your nose, combined with intensive exercise therapy, can help repair long-term spinal cord injuries. You'll receive a surgical procedure and then participate in structured rehabilitation five days a week for several months.
This trial tests a cell transplant approach for people with a very severe spinal cord injury. It focuses first on safety and also looks for early signs the therapy may improve function.
This trial tests a new treatment made from stem cells (called XS228CN) injected into the spine. It is primarily a safety study, but doctors will also watch for any signs the treatment may slow ALS progression.
Hear when a new Clinical Trials trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.